文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

外周组织低灌注预测插管后血流动力学不稳定

Peripheral tissue hypoperfusion predicts post intubation hemodynamic instability.
PubMed 文献 · Ann Intensive Care · 2022-07-18
一句话结论在需要插管的ICU患者中,插管前花斑评分是插管后血流动力学不稳定(PIHI)的最佳预测指标(AUC 0.72),校正后每增加1分OR 1.84。

这项前瞻性观察性单中心研究纳入18张床位的内科ICU中连续需要气管插管的120例患者,在插管前、插管后5分钟和2小时记录全局血流动力学和组织灌注参数,PIHI定义为需要治疗干预的任何血流动力学事件。42%(51例)患者发生PIHI;单因素分析中插管前去甲肾上腺素使用、脓毒症、心动过速、发热、较高SOFA和SAPS II评分、花斑评分≥3、高乳酸水平和膝部毛细血管再充盈时间延长与PIHI相关,而平均动脉压、基线心指数和射血分数在两组间无差异;校正混杂因素后花斑评分与PIHI风险升高相关(每增加1分校正OR 1.84 [1.21-2.82],p=0.005),基线花斑评分是PIHI的最佳预测指标(AUC 0.72 [95%CI 0.62-0.81])。作者认为组织低灌注参数尤其是花斑评分可能有助于预测PIHI。

要点

  • 插管前花斑评分每增加1分,校正后PIHI风险升高(校正OR 1.84 [1.21-2.82],p=0.005)。
  • 基线花斑评分是全局血流动力学和组织灌注参数中预测PIHI的最佳指标(AUC 0.72 [95%CI 0.62-0.81])。
  • 单因素分析中花斑评分≥3、高乳酸水平、膝部毛细血管再充盈时间延长与PIHI相关。
  • 平均动脉压、基线心指数和射血分数在PIHI组与无PIHI组之间无差异。
  • 120例插管患者中42%(51例)发生PIHI,48%有脓毒症、16%有脓毒性休克。

适用人群与场景

  • 18张床位的内科ICU中连续需要气管插管的患者,共120例,以男性为主(59%),中位年龄68岁 [57-77]。
  • 中位SOFA评分6 [4-9],中位SAPS II评分47 [37-63];插管主要指征为低氧血症(51%)、高碳酸血症(13%)和昏迷(29%);48%患者有脓毒症,16%有脓毒性休克。

诊断标准与关键阈值

  • 插管后血流动力学不稳定(PIHI)定义为需要治疗干预的任何血流动力学事件。

研究设计与关键结果

  • 前瞻性观察性单中心研究,纳入120例需要气管插管的ICU患者,在插管前、插管后5分钟和2小时记录全局血流动力学参数(血压、心率、心功能)和组织灌注参数(动脉乳酸、花斑评分、毛细血管再充盈时间、趾-室温梯度)。
  • 51例(42%)患者发生PIHI。
  • 单因素分析中与PIHI相关的基线因素包括:插管前去甲肾上腺素使用、脓毒症、心动过速、发热、较高SOFA评分、高SAPS II评分、花斑评分≥3、高乳酸水平、膝部毛细血管再充盈时间延长。
  • 平均动脉压、基线心指数和射血分数在PIHI组与无PIHI组之间无差异。
  • 校正潜在混杂因素后,花斑评分与PIHI风险升高相关(每增加1分校正OR 1.84 [1.21-2.82],p=0.005)。
  • 在全局血流动力学和组织灌注参数中,基线花斑评分是PIHI的最佳预测指标(AUC 0.72 [95%CI 0.62-0.81])。

证据类型、等级与局限

  • 证据类型:前瞻性观察性单中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在需要有创机械通气的非选择性重症患者中,组织低灌注参数尤其是花斑评分可能有助于预测PIHI。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Tracheal intubation and invasive mechanical ventilation initiation is a procedure at high risk for arterial hypotension in intensive care unit. However, little is known about the relationship between pre-existing peripheral microvascular alteration and post-intubation hemodynamic instability (PIHI).

METHODS: Prospective observational monocenter study conducted in an 18-bed medical ICU. Consecutive patients requiring tracheal intubation were eligible for the study. Global hemodynamic parameters (blood pressure, heart rate, cardiac function) and tissue perfusion parameters (arterial lactate, mottling score, capillary refill time [CRT], toe-to-room gradient temperature) were recorded before, 5 min and 2 h after tracheal intubation (TI). Post intubation hemodynamic instability (PIHI) was defined as any hemodynamic event requiring therapeutic intervention.

RESULTS: During 1 year, 120 patients were included, mainly male (59%) with a median age of 68 [57-77]. The median SOFA score and SAPS II were 6 [4-9] and 47 [37-63], respectively. The main indications for tracheal intubation were hypoxemia (51%), hypercapnia (13%), and coma (29%). In addition, 48% of patients had sepsis and 16% septic shock. Fifty-one (42%) patients develop PIHI. Univariate analysis identified several baseline factors associated with PIHI, including norepinephrine prior to TI, sepsis, tachycardia, fever, higher SOFA and high SAPSII score, mottling score ≥ 3, high lactate level and prolonged knee CRT. By contrast, mean arterial pressure, baseline cardiac index, and ejection fraction were not different between PIHI and No-PIHI groups. After adjustment on potential confounders, the mottling score was associated with a higher risk for PIHI (adjusted OR: 1.84 [1.21-2.82] per 1 point increased; p = 0.005). Among both global haemodynamics and tissue perfusion parameters, baseline mottling score was the best predictor of PIHI (AUC: 0.72 (CI 95% [0.62-0.81]).

CONCLUSIONS: In non-selected critically ill patients requiring invasive mechanical ventilation, tissue hypoperfusion parameters, especially the mottling score, could be helpful to predict PIHI.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Dubée V, Hariri G, Joffre J, et al. Peripheral tissue hypoperfusion predicts post intubation hemodynamic instability. Ann Intensive Care. 2022. PMID: 35843960. doi:10.1186/s13613-022-01043-3

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。